GDF11 as a friend or an enemy in the cancer biology?

Biochim Biophys Acta Rev Cancer. 2023 Sep;1878(5):188944. doi: 10.1016/j.bbcan.2023.188944. Epub 2023 Jun 24.

Abstract

The Growth and Differential Factor 11 (GDF11) is a recently discovered representative of Transforming Growth Factor β superfamily. The highest expression of GDF11 is detected in the nervous system, bladder, seminal vesicles and muscles whereas the lowest in the testis, liver or breast. GDF11 role in physiology is still not clear. GDF11 is a crucial factor in embryogenesis, cell cycle control and apoptosis, inasmuch it mainly targets cell retain stemness features, managing to the cell differentiation and the maturation. GDF11 is entangled in lipid metabolism, inflammatory processes and aging. GDF11 is strongly related to carcinogenesis and its expression in tumors is intruded. GDF11 can promote cancer growth in the colon or inhibit the cell proliferation in breast cancer. The aberrated expression is probably allied with the impaired maturation. In this article we summarized an impact of GDF11 on the tumor cells and review the all attitudes connecting GDF11 with carcinogenesis.

Keywords: Breast cancer; Cancer biology; GDF11; Liver cancer; Smad proteins; TGF-β pathway.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biology
  • Bone Morphogenetic Proteins* / metabolism
  • Bone Morphogenetic Proteins* / pharmacology
  • Cell Differentiation
  • Factor XI
  • Growth Differentiation Factors / metabolism
  • Growth Differentiation Factors / pharmacology
  • Humans
  • Male
  • Neoplasms*

Substances

  • Bone Morphogenetic Proteins
  • Factor XI
  • Growth Differentiation Factors
  • GDF11 protein, human